Technology

Entegris, Inc. (ENTG)

$16.9B
Market Cap
72.0
P/E Ratio
1.29
Beta
0.35%
Dividend Yield
Piotroski 5/9Altman Z 3.3 SafeBeneish M -2.60 CleanROIC−WACC -6.6%

Quantitative Summary

Deterministic

ENTG trades at 72.0x earnings, roughly in line with its sector average of 65.0x. Financial health is average: Piotroski 5/9, Altman Z 3.3.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of Entegris, Inc. reveal a capital allocation profile that warrants scrutiny given the ROIC-WACC spread sits at just 4.6%, indicating limited value creation relative to cost of equity. This modest return is driven primarily by low asset turnover of 0.38x within a DuPont decomposition where net margins of 7.4% and leverage of 2.11x provide only partial support, resulting in an ROE of merely 6.0%. While the Piotroski F-Score of 5/9 suggests moderate financial strength and the Beneish M-Score of -2.60 points to low earnings manipulation risk, these metrics contrast sharply with a revenue contraction of -1.4% year-over-year, signaling potential headwinds in core demand despite healthy gross margins near 44%.

Valuation multiples present a significant premium against the broader technology sector average; trading at 72.0x P/E compared to a peer group mean of 56.8x implies the market is pricing in substantial future growth that has not yet materialized, particularly as current earnings appear stagnant or declining. A discounted cash flow analysis suggests an intrinsic fair value of $56, which stands in stark contrast to the current multiple expansion embedded in the stock price. This divergence indicates that investors are currently assigning a high implied growth rate to the company's future prospects, a premise that may be fragile given the recent negative revenue trajectory and lack of demonstrated ROIC improvement.

Risk factors further complicate the investment thesis, highlighted by significant insider activity showing $29.6 million in net selling over the past 90 days, which often precedes downward revisions or reflects internal confidence issues absent from public filings. Although no specific Fama-French alpha data was provided to quantify style exposure, the combination of high valuation, shrinking top-line growth, and notable insider outflows creates a precarious risk/reward asymmetry where downside protection appears limited relative to the premium paid for future expectations.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →9.2%11.2%13.2%
2%$71$49$35
3%$83$56$39
4%$101$65$44

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=11.2%, terminal growth 3%. Fair value $56 (+0.0%). Not investment advice.

Valuation Context

72.0x
ENTG P/E
65.0x
Sector Avg
+11%
vs Sector

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
3.3
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.60
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

44.4%
Gross Margin
7.4%
Net Margin
4.6%
ROIC
11.2%
WACC
ROIC − WACC Spread: -6.6%— Negative spread.
-1.4%
Revenue Growth (YoY)
-19.5%
Earnings Growth (YoY)
396.2M
Free Cash Flow
15%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

7.4%
Net Profit Margin
NI ÷ Revenue
×
0.38x
Asset Turnover
Revenue ÷ Assets
×
2.11x
Equity Multiplier
Assets ÷ Equity
=
6.0%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

1.11x
Debt / Equity
3.35x
Current Ratio
2.3x
Interest Coverage
4.0x
Net Debt / EBITDA
1.96%
FCF Yield
844.1M
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$30M
Net Selling
0
Buy Transactions
7
Sale Transactions
2026-02-25LOY BERTRANDSold 3/8 qtrsSale$15M
2026-02-24LOY BERTRANDSold 3/8 qtrsGrant$965,206
2026-02-20LAGORGA LINDA ASold 1/8 qtrsGrant$1M
2026-02-20COLELLA JOSEPHSold 2/8 qtrsSale$207,754
2026-02-20BLACHIER OLIVIERSold 6/8 qtrsSale$218,799

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✗ Miss
Est: $0.68
Act: $0.67
-2.1%
Q3
✓ Beat
Est: $0.64
Act: $0.66
+3.1%
Q2
✗ Miss
Est: $0.72
Act: $0.72
-0.6%
Q1
✓ Beat
Est: $0.66
Act: $0.70
+5.4%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

25.3
Forward P/E
PEG Ratio
4.26
Price/Book
3M
Avg Volume
$142.50
52W High
$60.75
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$2.0B
Tracked Passive Exposure
8
ETFs Holding ENTG
0.08%
Avg Weight in ETFs
$2.7T
Total ETF AUM

When investors buy or sell ETFs like MDYV or VBK, the fund manager is mechanically forced to buy or sell ENTG shares regardless of Entegris, Inc.'s individual fundamentals. We estimate $2.0B of passive capital is structurally linked to ENTG through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in Entegris, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.

ENTG Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
ENTGEpicenterVTIETFVBETFVGTETFFLEXMed RiskFTILow RiskTWLOLow RiskCWLow RiskNVTLow Risk
ENTG Price Drop (%)0

If Entegris, Inc. (ENTG) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies FLEX LTD (FLEX) as the most exposed collateral stock, sharing 2 ETFs with ENTG. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 16 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

ENTG Ownership Dynamics

Ticker
ENTG

Float lock-up computed from 16 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

ENTG Capital Efficiency

How efficiently does Entegris, Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$396M
EBITDA
$844M
FCF Conversion
47%
Reinvestment Rate
53%
47% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
4.6%
ROIC − WACC Spread
-6.6%

Entegris, Inc. converts 47% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The 53% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-6.6%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-13133,707$145.31$19.4M
2026-05-1211,431$149.15$1.7M
2026-05-085,512$147.66$813,901.92
2026-05-076,205$155.86$967,111.3
2026-05-042$142.29$284.58
2026-04-301,851$149.37$276,483.87
2026-04-28156,970$156.44$24.6M
2026-04-20180$146.06$26,290.8
2026-04-16192$137.00$26,304
2026-04-082,180$118.55$258,439
2026-04-073,423$115.68$395,972.64
2026-04-0618,469$116.40$2.1M
2026-04-0185$117.24$9,965.4
2026-03-302$113.59$227.18
2026-03-261,841$123.18$226,774.38
2026-03-25105$121.67$12,775.35
2026-03-2314$114.66$1,605.24
2026-03-201,378$115.86$159,655.08
2026-03-171,428$111.64$159,421.92
2026-03-111,195$116.88$139,671.6
2026-03-0918$112.44$2,023.92
2026-03-03516$135.50$69,918
2026-03-0213,554$132.45$1.8M
2026-02-2611$137.34$1,510.74
2026-02-236$134.49$806.94
2026-02-2033$132.67$4,378.11
2026-02-192$131.89$263.78
2026-02-1244$137.79$6,062.76
2026-02-106$122.39$734.34
2026-02-095,135$122.37$628,369.95

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare ENTG to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.